Rocket Pharmaceuticals Ownership | Who Owns Rocket Pharmaceuticals?
Rocket Pharmaceuticals Ownership Summary
Rocket Pharmaceuticals is owned by 89.59% institutional investors, 3.25% insiders, and 7.16% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 15.77% of RCKT shares. Vanguard Health Care Inv is the top mutual fund, with 7.11% of its assets in Rocket Pharmaceuticals shares.
RCKT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rocket Pharmaceuticals | 89.59% | 3.25% | 7.16% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 17.69M | 15.77% | $60.49M |
| Blackrock funding, inc. /de | 9.92M | 8.85% | $33.94M |
| Vanguard group | 8.54M | 7.66% | $29.99M |
| Blackrock | 6.19M | 6.61% | $133.33M |
| Citigroup | 4.87M | 4.34% | $16.64M |
| Janus henderson group | 4.00M | 4.25% | $50.34M |
| Marshall wace, llp | 4.03M | 3.59% | $13.78M |
| Millennium management | 4.00M | 3.57% | $13.68M |
| Newtyn management | 4.00M | 3.57% | $13.68M |
| Maverick capital | 3.92M | 3.50% | $13.42M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 150.71K | 2.53% | $1.89M |
| Newtyn management | 4.00M | 1.71% | $13.68M |
| Boxer capital | 1.47M | 1.66% | $31.56M |
| M28 capital management lp | 210.87K | 1.53% | $721.18K |
| Lion point capital, lp | 86.00K | 1.41% | $294.12K |
| Monaco asset management sam | 2.48M | 0.67% | $8.48M |
| Cowen and company | 1.10M | 0.65% | $23.68M |
| Amitell capital pte | 178.77K | 0.56% | $611.39K |
| Rtw investments, lp | 17.69M | 0.52% | $60.49M |
| Prosight management, lp | 700.00K | 0.41% | $2.39M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 4.00M | 0.03% | 2.11M |
| Blackrock funding, inc. /de | 9.92M | 0.00% | 2.09M |
| Vanguard group | 8.54M | 0.00% | 1.65M |
| Jacobs levy equity management | 1.97M | 0.02% | 1.56M |
| Federated hermes | 2.30M | 0.01% | 1.28M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Westfield capital management co lp | - | - | -4.82M |
| Suvretta capital management | - | - | -2.99M |
| Nuveen | 199.79K | 0.00% | -2.93M |
| State street | 1.82M | 0.00% | -2.67M |
| Bioimpact capital | - | - | -1.59M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 749.07K | 0.00% | 749.07K | $2.56M |
| Bit capital gmbh | 298.00K | 0.03% | 298.00K | $1.02M |
| Nebula research & development | 100.78K | 0.02% | 100.78K | $246.91K |
| Weiss asset management lp | 86.06K | 0.00% | 86.06K | $294.34K |
| Man group | 62.58K | 0.00% | 62.58K | $204.00K |
Sold Out
| Holder | Change |
|---|---|
| Smartleaf asset management | -20.00 |
| Wealthspire advisors | -20.00 |
| Allspring global investments | -20.00 |
| First horizon advisors | -24.00 |
| Evermay wealth management | -25.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 182 | -11.22% | 100,457,791 | 3.35% | 89 | 1.17% | 90 | -29.69% | 64 | 20.75% |
| Mar 31, 2026 | 84 | -54.35% | 26,596,215 | -70.86% | 23 | 0.36% | 51 | -41.38% | 21 | -70.83% |
| Dec 31, 2025 | 114 | -37.36% | 46,937,731 | -51.45% | 42 | 0.55% | 55 | -40.86% | 41 | -31.67% |
| Sep 30, 2025 | 152 | -22.84% | 69,915,346 | -20.60% | 62 | 1.00% | 73 | -38.66% | 55 | 27.91% |
| Jun 30, 2025 | 204 | -17.07% | 94,897,210 | -11.80% | 85 | 0.89% | 123 | -23.13% | 44 | 2.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 7.60M | 7.11% | - |
| State Street® SPDR® S&P® Biotech ETF | 2.90M | 2.66% | -18.07K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.70M | 2.47% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.70M | 2.47% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.70M | 2.46% | - |
| RTW Biotech Opportunities Ord | 2.57M | 2.37% | 170.76K |
| iShares Russell 2000 ETF | 2.32M | 2.13% | -41.18K |
| Vanguard US Total Market Shares ETF | 2.21M | 2.08% | -245.50K |
| SPDR® S&P Biotech ETF | 1.79M | 1.66% | 10.61K |
| Nuveen Quant Small Cap Equity R6 | 1.72M | 1.57% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Wilson Martin | General Counsel | Sell | $2.13K |
| Aug 18, 2026 | Shah Gaurav | CEO | Sell | $7.75K |
| Aug 13, 2026 | Shah Gaurav | CEO | Sell | $9.59K |
| Aug 13, 2026 | Wilson Martin | General Counsel | Sell | $11.81K |
| Aug 11, 2026 | Stevens Christopher James | Chief Operating Officer | Sell | $128.27K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 6 |
| 2026 Q2 | - | 8 |
| 2026 Q1 | 1 | 6 |
| 2025 Q4 | - | 8 |
| 2025 Q3 | 1 | 10 |
RCKT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools